XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statement of Stockholders' Equity (unaudited) - 6 months ended Mar. 31, 2018 - USD ($)
Total
Common stock issued for cash at $5.25 per share
Common Stock
Common Stock
Common stock issued for cash at $5.25 per share
Additional Paid-In Capital
Additional Paid-In Capital
Common stock issued for cash at $5.25 per share
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Non-controlling Interest
Beginning Balance, Amount at Sep. 30, 2017 $ 80,867,162   $ 167,155   $ 514,037,301   $ 33,232 $ (432,815,338) $ (555,188)
Beginning Balance, Shares at Sep. 30, 2017     74,785,426            
Stock-based compensation 3,549,354       3,549,354        
Exercise of stock options, Amount $ 193,125   $ 79   193,046        
Exercise of stock options, Shares 79,374   79,374            
Exercise of warrants, Amount $ 666,230   $ 209   666,021        
Exercise of warrants, Shares     208,473            
Common stock- Restricted Stock Units vesting, Amount (54,668)   $ 997   (55,665)        
Common stock- Restricted Stock Units vesting, Shares     997,125            
Stock issuances   $ 56,585,035   $ 11,500   $ 56,573,535      
Stock issuances, Shares       11,500,000          
Foreign currency translation adjustments (7,967)           (7,967)    
Net loss for the six months ended March 31, 2018 (28,083,189)             (28,083,189)  
Ending Balance, Amount at Mar. 31, 2018 $ 113,715,082   $ 179,940   $ 574,963,592   $ 25,265 $ (460,898,527) $ (555,188)
Ending Balance, Shares at Mar. 31, 2018     87,570,398